Crispr Therapeutics Ag (CRSP)

Operating Income Growth

-16.58%

TTM · Period ending:

CRSP logo

CRSP Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-16.58%
CRSP TTM Operating Income YoY % (-164.80% → -16.58%)
High-resolution chart · PNG

CRSP operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Crispr Therapeutics Ag Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-16.583%
-15.9654%
-21.809%
-43.848%
-28.6285%
-58.8552%
-109.6563%
21.5426%
25.117%
46.8309%
66.9413%
38.3601%
25.2675%
-279.9673%
-280.217%
-267.0417%
-241.4954%
178.9341%
205.3869%
274.5782%
10,948.0262%
-1,932.4698%
-858.3119%
-2,388.5545%
97.9153%
111.9627%
129.4068%
91.5995%
-127.9739%
-154.3956%
-145.8591%
-23.9888%
-5.9912%
8.1855%
5.1108%
-65.3694%
-75.9844%
-129.52%
-164.7985%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.